HI
MRTX

Harbour Investments’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Harbour Investments’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-100
Closed -$3.61K – 3130
2023
Q2 		$3.61K Hold
100
– – ﹤0.01% 2376
2023
Q1 		$3.72K Buy
+100
New +$4.5K ﹤0.01% 2391

Other funds holding MRTX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Harbour Investments's MRTX Position: Q3 2023 in Review

Harbour Investments sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q3 2023, closing a stake of 100 shares — an estimated $3.61K sold.

Harbour Investments first reported a position in MRTX in Q1 2023 and held it in 2 quarters. The position peaked at $3.72K in Q1 2023. 213 funds tracked by Wall St. Rank hold MRTX as of Q3 2023.

  • Harbour Investments reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Harbour Investments sold 100 Mirati Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $3.61K.
  • Harbour Investments first reported a position in Mirati Therapeutics, Inc. Common Stock in Q1 2023 and held it in 2 quarters.
  • Harbour Investments's Mirati Therapeutics, Inc. Common Stock position peaked at $3.72K in Q1 2023.
  • 213 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Harbour Investments's 13F filing for Q3 2023, filed 15 Nov 2023.